Eric Holt-Giménez
Eric Holt-Giménez has been Executive Director of Food First since 2006. He is the editor of the Food First book Food Movements Unite! Strategies to Transform Our Food Systems; co-author of Food Rebellions! Crisis and the Hunger for Justice with Raj Patel and Annie Shattuck; and author of the book Campesino a Campesino: Voices from Latin America’s Farmer to Farmer Movement for Sustainable Agriculture and of many academic, magazine and news articles. Of Basque and Puerto Rican heritage, Eric grew up milking cows and pitching hay in Point Reyes, California, where he learned that putting food on the table is hard work. After studying rural education and biology at the University of Oregon and Evergreen State College, he traveled through Mexico and Central America, where he was drawn to the simple life of small-scale farmers.
POPULAR
Norway reaches historic milestone as electric vehicles outnumber petrol cars for the first time
Norway’s rapid transition to electric vehicles, a global first, shows the impact of policy incentives and ambitious climate goals, setting the pace for the rest of the world.
Trump-appointed judges continue assault on workers’ rights by undermining NLRB
In a move that could reshape labor rights across the country, these judges are granting preliminary injunctions to companies that argue the NLRB’s structure violates the U.S. Constitution.
Sisyphus Trump maniacally replays 2015, with repeated, inflammatory media blitzes. But that gambit...
How many unforced errors—the Arlington cemetery mess, JD Vance, fake Ohio pet-napping and Loomer—confirm Trump as monumental scatterbrain?
Forests thrive when Indigenous people have legal stewardship of their land
The fate of intact forests is closely linked to that of Indigenous peoples.
Bernie Sanders calls out Big Pharma over exorbitant drug prices: Novo Nordisk’s $900+...
As Novo Nordisk rakes in billions, Sen. Bernie Sanders and public health advocates demand answers on why U.S. patients are charged sky-high prices for life-saving drugs like Ozempic while generics could sell for a fraction of the cost.